Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria

Conditions

• Hypertension

Interventions

• DRUG: Irbesartan
• DRUG: placebo

Sponsor

Sanofi

Collaborators

• [object Object]